DR. MICHAEL D LUTZ MD NPI 1326020157

NPI Details

DR. Michael D Lutz, MD is an urology in Rochester Hills, MI with 45 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Michael D Lutz, MD NPI is 1326020157. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Graduation Year:1981

The provider's business location address is:

1701 SOUTH BLVD E
STE 340
ROCHESTER HILLS, MI
ZIP 48307-122
Phone: (248) 293-1000
Fax: (248) 293-1001

The NPI 1326020157 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Testosterone (hormone) level, total (HCPCS:84403)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Liver function blood test panel (HCPCS:80076)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Testosterone (hormone) level, free (HCPCS:84402)
• Vitamin d-3 level (HCPCS:82306)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Biopsy of prostate gland (HCPCS:55700)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 11/17/2005 and was last updated on 3/28/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: